Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Combogesic® IV in Pediatric Patients With Acute Pain
NCT07225634Phase 3Recruiting
- Sponsor
- AFT Pharmaceuticals
- Start
- Sep 2026
- Primary completion
- Mar 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of acetaminophen + ibuprofen in acute pain, sponsored by AFT Pharmaceuticals. Started Sep 2026; status: recruiting.
02
Drugs
acetaminophen + ibuprofen
03
Conditions
acute pain
Beyond the preview
Go deeper on NCT07225634.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07225634.